Soon, no more blood tests or probing for prostate cancer? AI claims 99% success rate using more relaxing methods

 By theregister - 2021-01-28

Description

Small-scale test involving biosensor and trained algorithms shows early promise

Summary

  • Oh no, you're thinking, yet another cookie pop-up.
  • By measuring this change after a tiny drop of urine is placed on the biosensor’s surface, scientists can determine the concentration of the biomarkers in the fluid.
  • First, a validation of our approach with a much larger data set should be checked.
  • At the moment, Lee believes the test is not yet good enough to completely eradicate the need for further biopsy tests.

 

Topics

  1. Management (0.28)
  2. Backend (0.19)
  3. Database (0.11)

Similar Articles

How adaptive computing solves AI productization challenges

By TechTalks - 2021-03-10

By Nick Ni The field of artificial intelligence moves swiftly, with the pace of innovation only accelerating. While the software industry has been successful in deploying AI in production, the hardwar ...

Machine Learning in Fintech - Demystified

By datasciencecentral - 2020-11-24

Abstract – Big data helps to make strategy for future and understand user behaviors. In 1959, Arther Samuel gave very simple definition of Machine Learning as…

AI in Healthcare: A review of innovative startups

By KDnuggets - 2020-12-15

The AI innovation in healthcare has been overwhelming with the Global Healthcare AI Market accounting for $0.95 billion in 2017, and is expected to reach $19.25 billion by 2026. What drives this vibra ...